Table 2 Demographic characteristics of febrile neonates and infants 90 days or younger during the COVID-19 pandemic period (March 2020-December 2022) by the result of the SARS-CoV-2 test
Total(n = 193) | SARS-CoV-2 positive(n = 71) | SARS-CoV-2 negative(n = 122) | p-value | |||||
|---|---|---|---|---|---|---|---|---|
No | (%) | No | (%) | No | (%) | |||
Gender | Female | 83 | (43.0) | 37 | (52.1) | 46 | (37.7) | 0.051 |
Male | 110 | (57.0) | 34 | (47.9) | 76 | (62.3) | ||
Age group (days) | 0–21 | 52 | (26.9) | 11 | (15.5) | 41 | (33.6) | 0.050 |
22–28 | 18 | (9.3) | 8 | (11.3) | 10 | (8.2) | ||
29–60 | 82 | (42.5) | 41 | (57.7) | 41 | (33.6) | ||
61–90 | 41 | (21.2) | 11 | (15.5) | 30 | (24.6) | ||
Median (IQR) | 39 | (19–57) | 40 | (27–53) | 35 | (16–60) | 0.784 | |
Comorbidities | None | 153 | (79.3) | 58 | (81.7) | 95 | (77.9) | 0.338 |
One | 10 | (5.2) | 10 | (14.1) | 25 | (20.5) | ||
Two or more | 3 | (1.6) | 3 | (4.2) | 2 | (1.6) | ||
Premature birth | 11 | (5.7) | 3 | (4.2) | 8 | (6.6) | 0.500 | |